Blue Earth Diagnostics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 100

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $466M

Blue Earth Diagnostics General Information

Description

Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions. The company imaging agents can be used for PET imaging to detect and localize prostate cancer in men with the diagnosis of biochemical recurrence as well as in amino acid transport and radiopharmaceutical therapies, enabling medical practitioners to diagnose and treat brain and prostate cancer patients with improved efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • The Oxford Science Park
  • Magdalen Centre, Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Earth Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Aug-2019 $466M 000.00 00000 Completed Profitable
1. Early Stage VC 11-Mar-2014 000.00 000.00 Completed Startup
To view Blue Earth Diagnostics’s complete valuation and funding history, request access »

Blue Earth Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions.
Drug Discovery
Oxford, United Kingdom
100 As of 2019
000.00
0000 0000-00-00
000000&0 000.00

000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
Inglewood, CA
00 As of 0000
000.00
00000000000 000.00

000000

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000 000000000
Eveleigh, Australia
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blue Earth Diagnostics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImaginAb Venture Capital-Backed Inglewood, CA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Eveleigh, Australia 00 00000 00000000 00000
000000 0000000 Formerly VC-backed Richland, WA 00 000.00 00000000 000.00
000 00000000 00000 Private Equity-Backed Munich, Germany 000 00000 000000000000 00000
0-0000 Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
You’re viewing 5 of 7 competitors. Get the full list »

Blue Earth Diagnostics Patents

Blue Earth Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210290783-A1 Imaging of metastatic or recurrent cancer Pending 30-Dec-2015 00000000000
US-20190105411-A1 Imaging of metastatic or recurrent cancer Granted 30-Dec-2015 00000000000
US-20170189565-A1 Imaging of metastatic or recurrent cancer Granted 30-Dec-2015 00000000000
US-20200316227-A1 Imaging of metastatic or recurrent cancer Granted 30-Dec-2015 00000000000
US-10933147-B2 Imaging of metastatic or recurrent cancer Active 30-Dec-2015 A61K51/0402 0
To view Blue Earth Diagnostics’s complete patent history, request access »

Blue Earth Diagnostics Executive Team (17)

Name Title Board Seat Contact Info
David Gauden Chief Executive Officer, Chief Scientific Officer & President
Michael Heslop President
Matthew Miller Ph.D Vice President, Research & Development Operations
Jonathan Allis Ph.D Chairman
Eugene Teoh Chief Medical Officer
You’re viewing 5 of 17 executive team members. Get the full list »

Blue Earth Diagnostics Board Members (5)

Name Representing Role Since
Elisa Petris Ph.D Syncona Board Member 000 0000
Jonathan Allis Ph.D Blue Earth Diagnostics Chairman 000 0000
Martin Murphy Ph.D Self Chairman 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Blue Earth Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial